Hantz Financial Services Inc. Purchases 23,073 Shares of Enovis Co. (NYSE:ENOV)

Hantz Financial Services Inc. increased its position in Enovis Co. (NYSE:ENOV - Free Report) by 10.3% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 247,469 shares of the company's stock after buying an additional 23,073 shares during the quarter. Hantz Financial Services Inc. owned 0.44% of Enovis worth $10,859,000 as of its most recent filing with the Securities & Exchange Commission.

Several other hedge funds also recently made changes to their positions in ENOV. UMB Bank n.a. increased its stake in shares of Enovis by 128.2% in the fourth quarter. UMB Bank n.a. now owns 778 shares of the company's stock worth $34,000 after buying an additional 437 shares during the period. Pinnacle Bancorp Inc. increased its stake in shares of Enovis by 54.5% in the fourth quarter. Pinnacle Bancorp Inc. now owns 850 shares of the company's stock worth $37,000 after buying an additional 300 shares during the period. DekaBank Deutsche Girozentrale purchased a new position in shares of Enovis in the third quarter worth $55,000. FMR LLC increased its stake in shares of Enovis by 20.5% in the third quarter. FMR LLC now owns 2,840 shares of the company's stock worth $122,000 after buying an additional 484 shares during the period. Finally, Heritage Family Offices LLP purchased a new position in shares of Enovis in the third quarter worth $206,000. 98.45% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

Separately, Needham & Company LLC reissued a "buy" rating and set a $65.00 price objective on shares of Enovis in a research report on Thursday, November 7th. One research analyst has rated the stock with a hold rating and six have assigned a buy rating to the company's stock. According to MarketBeat, the company currently has an average rating of "Moderate Buy" and an average target price of $65.86.

Enovis Trading Down 1.2 %

Enovis stock traded down $0.58 during mid-day trading on Friday, reaching $46.94. 517,529 shares of the company traded hands, compared to its average volume of 1,194,480. The firm's 50 day moving average price is $46.10 and its 200 day moving average price is $44.53. The firm has a market capitalization of $2.67 billion, a price-to-earnings ratio of -21.43 and a beta of 1.94. The company has a debt-to-equity ratio of 0.40, a current ratio of 2.27 and a quick ratio of 1.12. Enovis Co. has a 52-week low of $38.27 and a 52-week high of $65.03.

Enovis (NYSE:ENOV - Get Free Report) last released its earnings results on Wednesday, November 6th. The company reported $0.73 earnings per share for the quarter, topping analysts' consensus estimates of $0.62 by $0.11. The firm had revenue of $505.22 million for the quarter, compared to the consensus estimate of $504.44 million. Enovis had a negative net margin of 5.95% and a positive return on equity of 4.39%. The company's revenue was up 21.0% compared to the same quarter last year. During the same period in the prior year, the firm earned $0.56 EPS. On average, analysts anticipate that Enovis Co. will post 2.79 earnings per share for the current fiscal year.

Enovis Company Profile

Enovis Corporation operates as a medical technology company focus on developing clinically differentiated solutions worldwide. It also manufactures and distributes medical devices which are used for reconstructive surgery, rehabilitation, pain management, and physical therapy. The company operates through Prevention and Recovery, and Reconstructive segments.